Thu, Jul 24, 2014, 9:52 AM EDT - U.S. Markets close in 6 hrs 8 mins

Recent

% | $
Click the to save as a favorite.

Affymax, Inc. (AFFY) Message Board

  • godwinpeak godwinpeak Jun 19, 2013 11:36 PM Flag

    Let's Take a Look at AFFY's Cash

    From AFFY's 1stQ 2013, AFFY had just $5.064M Net cash calculated as follows:
    Cash and cash equivalents, plus Short-term investments, plus Long-term investments = $55.049M
    Less: Total fixed contractual obligations of $49.985M
    = $5.064M net cash available for operations

    Now since then, AFFY has paid (1) $5.975M to Lonza and Nektar and (2) $5M to Bachem Americas for cancellation of manufacture of O's active pharmaceutical ingredient for a total of $10.975M.

    AFFY's 10Q disclosed that it had $32.35M in manufacturing obligation to be paid in 2013. Assuming, for arguments sake only, that the $10.975M in payments satisfied THE ENTIRE $32.35M of AFFY's outstanding manufacturing obligations, then the payments to Lonza, Nektar and Bachem could be expected to improve AFFY's disclosed "free cash" by $21.375M. Adding that figure to the $5.06M previously calculated net cash, means that AFFY, at best, would have $26.435M of net cash available for operations as of the 3/31/13 financial disclosures.

    With no revenues and $26.435M net cash, AFFY must

    - Fund ongoing operations.
    - Pay termination compensation to its officers.
    - Pay restructuring costs for termination of the remaining 25% of its workforce.
    - Pay Healthstar Clinical Education Solutions, LLC for breach of contract claim Case No. 1-13-CV-245581
    Superior Ct Santa Clara Cty, CA).
    - Pay for the defense/liability of the shareholder derivative action to the extent not covered by insurance, if any, In re Affymax, Inc., Shareholder Derivative Litigation, Case No. 1-13-CV-243259, Consolidated with Markland v. Orwin, et al., Case No. 1-13-CV-243962 (Superior Ct Santa Clara Cty, CA)
    - Pay for the defense/liability of securities class action to the extent not covered by insurance in Bartelt v. Affymax, et al., Case No. 13-cv-01025-JPH (ND CA).
    -Pay for defense/liability of products liabilities claims in connection with O.
    - Pay for indemnification of its officers' litigation expenses and liabilities not covered by insurance.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • gadflypeckerhead, either this is yet another alias of yours or you two need to get a room! And you know what is cumming next...cash your aesss! Lolololol

    • What amazes me is how longs here will label you a "basher" and make all sorts of ad hominem attacks on you, when all you are doing is presenting factual information that can be verified through the company's own SEC filings (unlike Maxdad who provides mostly speculation and, in his words, "filling in the blanks" (or "making things up" as I call it)). You have presented a very rational case as to why it does not look very good for AFFY to last long enough for O to make it back to market (if it ever does, which I have my doubts that it ever will).

      Sentiment: Strong Sell

 
AFFY
0.100.00(0.00%)9:34 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.